Comments on: Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis

Comments on: Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis https://www.novumpr.nl/2019/09/09/data-from-ozanimod-clinical-development-program-in-relapsing-forms-of-multiple-sclerosis-to-be-presented-at-the-35th-congress-of-the-european-committee-for-treatment-and-research-in-multiple-sclerosis/?utm_source=rss&utm_medium=rss&utm_campaign=data-from-ozanimod-clinical-development-program-in-relapsing-forms-of-multiple-sclerosis-to-be-presented-at-the-35th-congress-of-the-european-committee-for-treatment-and-research-in-multiple-sclerosis NovumPR press releases Mon, 09 Sep 2019 12:10:56 +0000 hourly 1 https://wordpress.org/?v=6.8.3